How Much Does Stem Cell Therapy in Colombia Really Cost?
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Cost & value How Much Does Stem Cell Therapy in Colombia Really Cost? What drives the price, how Colombia compares with Mexico, Panama and the United States, and what an all-inclusive package actually covers. By Dr. Diana ReyesAugust 2026 In short: At Stem Cells Colombia, one joint treatment starts at US$3,500, all-inclusive — cells, operating-room procedure, hotel, transfers and follow-up. Prices across the industry vary widely because clinics differ in cell source, passage number, dose, setting and what the quoted figure actually covers. This page explains what drives the price so you can compare like with like. What actually determines the price Cell product type Autologous preparations come from your own body; allogeneic cells come from a screened donor. Umbilical cord–derived mesenchymal stromal cells (UC-MSCs) originate from neonatal tissue, with fewer cell divisions and less lifetime exposure to oxidative stress and DNA damage than adult cells. The literature describes UC-MSCs as showing longer telomeres, higher proliferative capacity, lower markers of cellular senescence and a more active paracrine secretome than bone marrow– or adipose-derived cells. What this means clinically for any individual patient is still being studied. Lab-expanded allogeneic cells typically cost more than simple autologous concentrates, because manufacturing, testing and quality control cost more. Dose and number of sessions Higher cell counts and serial injections increase the total. A quote for “stem cell therapy” without a cell count is not a quote you can compare. Procedure setting and technique Procedures performed in an operating room under sedation with fluoroscopic or ultrasound guidance — intradiscal, epidural, intra-articular — cost more than an injection given in a consulting room. That difference is the point, not overhead. Lab quality and compliance GMP-style processing, sterility testing, viability assays and traceability add cost and are the reason a cell product can be relied upon. Pre- and post-procedure care Consultations, imaging review, rehabilitation programmes and follow-up are part of the real cost of treatment, whether or not a clinic includes them in the headline number. Geography Local pricing norms, clinic reputation and physician experience all move the figure. How prices compare between countries These are approximate starting points for a single joint, based on what clinics in each market typically advertise. They move over time and differ between providers, so treat them as orientation and verify directly with any clinic you are considering. Colombia: from about US$3,500 — at our centre, hotel and transfers included. Mexico: from roughly US$3,000, accommodation usually not included. Panama: from roughly US$5,000, accommodation usually not included. United States: quoted figures vary very widely, from several thousand dollars to over US$20,000 depending on the protocol, and typically exclude travel, accommodation and follow-up. The headline number is rarely the comparable number. A lower price that excludes accommodation, transfers and follow-up consultations can end up costing more than a higher all-inclusive package. What our price includes Passage 3 cells: umbilical cord Wharton’s jelly mesenchymal stem cells, processed under controlled protocols to maintain viability and consistent dosing. One joint treatment includes 50–100 million cells. Operating-room procedures: all spine injections are performed in the operating room under sedation with fluoroscopic guidance. Joint treatments are performed under local anaesthesia with ultrasound guidance. Not in a consulting room. Experienced team: physicians with extensive spine and joint procedure experience, and standardised follow-up protocols. All-inclusive package: pre-procedure evaluation, imaging review, the cell product, procedure fees, structured rehabilitation, hotel accommodation and transfers. No hidden fees: the figure you are quoted is the figure you pay. See the full breakdown on our pricing page, or read about the cells we use and what Passage 3 means. Why Colombia can offer competitive pricing Lower operating costs: labour, facility and overhead expenses are lower than in many high-cost countries, which allows lower pricing without reducing quality. Established medical expertise: Colombia has many experienced physicians and surgical teams trained in advanced interventional and regenerative techniques, often with international training and high procedural volumes. Efficient care pathways: shorter waiting times, streamlined scheduling and integrated packages reduce indirect costs. Medical-tourism ecosystem: currency advantages and a mature medical-travel network reduce the total cost of the trip compared with treatment in North America or Europe. How to evaluate price against value Ask any provider you are considering: What is the cell source and the passage number? How many viable cells are delivered, and is viability verified by an independent laboratory? Is the procedure performed in an operating room, and is image guidance used? Is follow-up included, and for how long? Is the hotel in the same building as the procedure, or will you be travelling across the city after treatment? Is there a team of physicians, or one doctor performing every type of application? Choose a centre on quality controls and clear outcome measures rather than on the lowest price alone — and on how clearly they answer your questions before you have paid anything. Frequently asked questions How much does stem cell therapy cost in Colombia? At Stem Cells Colombia, one joint treatment starts at US$3,500, all-inclusive: cells, operating-room procedure, hotel, transfers and follow-up. The final figure depends on the number of areas treated and the protocol your case requires. Why is it cheaper than in the United States? Lower operating and labour costs, and a mature medical-travel infrastructure. The regulatory context also differs:
Biohacking with Stem Cell Therapy: Promise, Pitfalls and Practical Guidance
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Longevity & biohacking Biohacking with Stem Cell Therapy: Promise, Pitfalls and Practical Guidance What the evidence supports, what remains experimental, and how to tell a serious programme from a sales pitch. By Dr. Diana ReyesAugust 2026 In short: Mesenchymal stem cell therapy has plausible mechanisms and early clinical evidence for specific localised conditions — joints, tendons, some discogenic pain. High-quality trials showing durable systemic anti-ageing or performance benefits do not exist yet. For anyone approaching this from a biohacking angle, the honest sequence is: exhaust the proven basics first, then consider cell therapy for indications with supporting evidence, and choose a provider on transparency rather than promises. What people mean by biohacking with stem cells Biohacking — the pursuit of optimising health, performance and longevity through lifestyle, technology and novel therapies — has drawn growing interest in regenerative medicine. Biohackers typically seek improvements in energy, recovery, cognitive function, joint health, metabolic markers and age-related decline. Stem cell interventions offered under this umbrella usually involve MSC injections delivered intravenously, intramuscularly, intra-articularly, intradiscally or epidurally, often combined with adjuncts such as exosomes, platelet-rich plasma or metabolic interventions like NAD+ infusions. What the science supports Mechanisms: MSCs act largely through paracrine signalling — secreting cytokines, growth factors and extracellular vesicles that can modulate inflammation and support tissue microenvironments. This part is well described. Localised conditions: for mild-to-moderate osteoarthritis, certain tendon injuries and some discogenic pain, early clinical studies report symptom improvement. Systemic use: intravenous administration for generalised anti-ageing effects remains experimental. High-quality randomised trials showing clear, durable systemic anti-ageing or performance-enhancing effects are lacking. Patients sometimes describe subjective changes after systemic treatment — better sleep, less fatigue, less brain fog. These reports are anecdotal, are not controlled for placebo effect, and should not be read as evidence that the treatment produces those effects. We mention them because patients ask, not as a claim. Where the realistic benefits are Reduced inflammation and symptomatic improvement in targeted conditions such as joints and certain spinal indications. Support for recovery from injury when used alongside structured rehabilitation. Possible quality-of-life improvement in selected conditions that have resisted standard care. How to evaluate a legitimate programme Transparency: the clinic states the cell source, passage number, processing method, dose, sterility testing and expected outcomes without being pushed. Medical oversight and selection: treatment is recommended by qualified clinicians after medical evaluation, imaging review and optimisation of conventional therapies — not sold from a price list. Protocols and monitoring: standardised protocols and scheduled follow-up visits. Regulatory compliance: adherence to local regulations, good manufacturing practice where applicable, and ethical standards. Practical guidance if you are considering it Do the proven things first. Diet, exercise, sleep, stress management and control of chronic disease have far stronger longevity and performance evidence than any injectable. They should precede invasive interventions, not follow them. Favour evidence-supported indications. Prefer therapies with clinical data for a specific condition over general anti-ageing claims. Ask the right questions. What is the cell source and passage number? How many viable cells are delivered? Is the procedure performed in a sterile operating-room environment, under imaging guidance where indicated? What are the documented risks and the expected timeline? Watch for red flags. Guarantees of dramatic results, vague protocols, no informed consent, no follow-up, or pressure to buy repeat packages are all warnings. Frequently asked questions Does IV stem cell therapy slow ageing? There is no reliable clinical evidence that it does. Systemic administration for anti-ageing purposes is experimental. Anyone stating otherwise is going beyond the published data. What about exosomes and NAD+? Both are commonly bundled into biohacking protocols. Mechanistic rationale exists; robust outcome data in humans is limited. Treat them the same way — as options under study, not established treatments. What is a reasonable expectation? For a targeted joint or spine problem, meaningful symptom improvement is a reasonable thing to hope for and to measure. For systemic optimisation, the honest expectation is uncertainty. How do I know if a clinic is serious? Ask for the passage number of the cells. A clinic that cannot or will not answer that has told you what you need to know. Conclusion Stem cell therapies offer plausible mechanisms and promising early results for certain targeted conditions. The prudent sequence is to exhaust proven lifestyle and medical measures first, consider MSC treatment only for indications with supporting evidence or within clinical trials, and choose providers who practise transparency, rigorous protocols and long-term follow-up. You can read about the cells we use and what Passage 3 means, or explore our anti-ageing and vitality protocol. This article is for general information and does not constitute medical advice. Stem cell therapy does not guarantee results and is not a cure. Eligibility requires review of your medical history by a physician. Individual results vary. Talk to our medical team ← Keep reading Welcome to Medellín Your treatment can start this week. No months-long waitlist. Message us and a real person — Mía — will get back to you in minutes. Message us on WhatsApp Book your consultation A leading center in regenerative medicine, dedicated to pain relief and health you can feel. Explore Treatments How it works Testimonials Pricing Blog FAQs Book Company About Dr. Diana Reyes The team Facilities About Medellín Contact WhatsApp +57 310
Spine Surgery: When It’s Necessary and When Regenerative Medicine Is an Option
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Spine, neck & back Spine Surgery: When It’s Necessary and When Regenerative Medicine Is an Option Which spine conditions genuinely need an operation, which do not, and where image-guided regenerative treatment fits. By Dr. Diana ReyesAugust 2026 In short: Some spine conditions genuinely require surgery — progressive neurological deficit, instability, fracture, infection or tumour. Most degenerative back and neck pain does not, at least not first. For selected patients with early-to-moderate disc degeneration or inflammatory pain, regenerative approaches including mesenchymal stem cell injections may reduce pain and postpone surgery. When spine surgery is indicated Surgery is considered when non-surgical care has failed or when there is an urgent structural problem. Typical indications include: Progressive or severe neurological deficit — motor weakness, or loss of bowel or bladder control — suggesting spinal cord or cauda equina compression. Persistent, disabling pain that does not respond to an adequate trial of conservative therapy and significantly limits daily function. Structural instability, such as spondylolisthesis with instability, or deformity requiring correction. Severe degenerative disc disease or foraminal stenosis causing radiculopathy, with imaging that correlates with the clinical findings. Fracture, infection or tumour, where operative management is required. If you have progressive weakness or any loss of bowel or bladder control, this is not a situation for elective decision-making. Seek urgent medical assessment. Common spine operations Decompression (laminectomy, discectomy): relieves nerve compression. Spinal fusion: stabilises unstable segments causing pain or deformity. Disc replacement: preserves motion in selected patients. Minimally invasive and endoscopic techniques: reduce tissue trauma and speed recovery in appropriate cases. Non-surgical options to try first For most degenerative spine conditions, a structured conservative pathway is recommended before elective surgery: Education and activity modification. Targeted physical therapy and graded exercise focusing on strength, flexibility and core stability. Analgesics, short courses of oral anti-inflammatories, and neuropathic agents as indicated. Image-guided epidural steroid injections or selective nerve root injections for radicular pain or inflammatory flares. Bracing or orthoses in selected cases. Multidisciplinary pain management when needed. What regenerative medicine offers for spine conditions Regenerative approaches — most commonly mesenchymal stem cell (MSC) therapies and biologic adjuncts — aim to reduce inflammation, modulate immune responses and support tissue repair. Applications in the spine may include: Intradiscal injection for early-to-moderate degenerative disc disease, to reduce inflammatory cytokines. Epidural or perineural delivery to modulate radicular inflammation and reduce pain. Facet joint or paraspinal soft tissue injection to address localised degenerative or inflammatory pain generators. What patients report Symptom mitigation: some patients report reduced pain and improved function after MSC-based therapies, particularly for axial low back pain from discogenic sources or inflammatory radiculopathy. Possible delay of surgery: for selected patients with early-to-moderate degeneration, symptom improvement can postpone the need for decompression or fusion. Short-term safety in regulated settings: with sterile technique, proper screening and standardised protocols, adverse events reported in published studies are generally mild and transient. Adjunctive role: these treatments are combined with rehabilitation and lifestyle measures rather than used in isolation. The evidence base for intradiscal cell therapy is still early. Studies are small, protocols differ between centres, and long-term data is limited. This is a reasonable option to discuss for the right patient, not an established alternative to surgery for everyone. How the procedure is performed here At Stem Cells Colombia our physicians perform direct, image-guided injections into intervertebral discs, facet joints and the cervical, thoracic or lumbar epidural space. These are carried out in the operating room under sedation, using continuous fluoroscopic guidance for precise placement, by a dedicated spine team, following strict sterile technique, standardised protocols and structured follow-up. Precise placement is the part most clinics cannot offer, because it requires an operating room and live imaging rather than an office setting. How we approach the decision Comprehensive assessment: we correlate symptoms, neurological examination and imaging to identify the pain generator and determine whether the conservative, regenerative or surgical pathway is appropriate. Informed consent and outcome tracking: for patients electing stem cell therapy, we use standardised protocols and schedule follow-up to monitor response and safety. See our spine and disc treatment or read about the cells we use. Who may be a candidate Patients with chronic axial low back pain attributed to early-to-moderate disc degeneration, without severe canal stenosis or progressive neurological deficit. Patients with radicular pain driven primarily by inflammatory irritation rather than mechanical compression that would be better addressed by decompression. Individuals seeking to delay major surgery who understand that this field is still developing, that costs are out of pocket, and that outcomes vary. Frequently asked questions Can stem cell therapy avoid spine surgery? It may postpone it for selected patients with early-to-moderate degeneration. It does not correct instability, deformity or nerve compression, and it is not an alternative when there is a progressive neurological deficit. Is an intradiscal injection safe? In published studies, adverse events with sterile technique and image guidance are generally mild and transient. Any injection into a disc carries risk, which is why we perform it in an operating room under fluoroscopic guidance rather than in an office. How do you know which structure is causing my pain? By correlating your symptoms, neurological examination and imaging. When those three do not agree, more diagnostic work is needed before any treatment — regenerative or surgical. What
Alternatives to Hip Replacement Surgery: When to Consider Stem Cell Therapy
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Hip Alternatives to Hip Replacement Surgery: When to Consider Stem Cell Therapy Conservative care, the role of mesenchymal stem cells, and the situations where hip replacement remains the most reliable option. By Dr. Diana ReyesAugust 2026 In short: Hip replacement is a well-established solution for advanced hip osteoarthritis. For many patients, conservative care meaningfully reduces pain first. Mesenchymal stem cell therapy is an evidence-informed but still developing option for selected patients with mild-to-moderate disease who want to postpone arthroplasty. For severe structural damage, replacement remains the more reliable choice. Non-surgical options to try first Education and activity modification: joint protection, pacing and lifestyle adaptation. Exercise and physical therapy: strengthening of hip abductors and core, gait training and flexibility work to reduce load and improve mechanics. Weight management: losing weight reduces joint stress and correlates with symptom improvement. Analgesics and anti-inflammatories: acetaminophen and NSAIDs, topical or oral, used judiciously. Intra-articular corticosteroid injections: short-term relief for flares, and useful for diagnostic clarification. Supports and orthoses: cane use, shoe modifications and targeted bracing where indicated. What stem cell therapy is, and how it may help Stem cell therapy for hip pain typically uses mesenchymal stem cells (MSCs). At Stem Cells Colombia these are derived from umbilical cord Wharton’s jelly. The cells act primarily through paracrine mechanisms: they secrete anti-inflammatory cytokines, growth factors and extracellular vesicles that modulate the joint environment, reduce chronic inflammation and support tissue repair processes. They are delivered by image-guided intra-articular injection into the hip, or targeted to periarticular structures. Potential benefits reported in the literature Pain reduction: clinical studies and case series report clinically meaningful decreases in pain scores for some patients with mild-to-moderate hip osteoarthritis. Functional improvement: many treated patients report better mobility, walking tolerance and activity participation. Possible delay of surgery: for selected patients, symptom relief can defer the need for arthroplasty by months to years — particularly relevant for younger patients. Safety profile in regulated settings: with proper sterility, patient screening and standardised protocols, reported short- to mid-term adverse events are typically mild and transient, such as soreness or temporary swelling. Adjunct to multimodal care: the approach works best combined with rehabilitation, weight management and activity modification. Evidence summary and realistic expectations Research on MSCs for hip osteoarthritis is promising and still evolving. Systematic reviews suggest potential benefits in pain and function for selected patients, while noting that study sizes are small, protocols vary widely between centres and follow-up is often short. Stem cell therapy should therefore be understood as an evidence-informed but still developing option — appropriate for patients who have exhausted optimised conservative therapy and who understand that outcomes vary and results cannot be guaranteed. When hip replacement remains the right choice Hip arthroplasty is generally indicated when: Severe pain substantially limits daily activities or sleep despite optimised non-surgical care. Imaging shows advanced joint destruction, severe joint-space loss, deformity or structural instability. Patient selection at Stem Cells Colombia Comprehensive evaluation: we confirm that guideline-based conservative care has been tried, review imaging and medical history, and assess goals and expectations. Individualised recommendation: if you are a candidate — typically mild-to-moderate osteoarthritis, suitable health status, realistic goals — we discuss the protocol, likely outcomes, costs and follow-up. Integrated care: stem cell therapy is offered as part of a multimodal plan including structured rehabilitation and outcome tracking. See our hip regeneration treatment or read about the cells we use. Frequently asked questions Can stem cell therapy replace hip surgery? No. It may relieve symptoms and postpone surgery in selected patients with mild-to-moderate disease, but it does not reverse advanced structural damage. Where the joint is severely destroyed, replacement remains the more reliable option. How soon would I notice a change? Patients who respond typically report gradual change over weeks to a few months rather than immediately. Some patients notice little difference. Structured follow-up is how we assess your actual response. Is it painful, and how long is the recovery? The injection is image-guided and performed under local anaesthesia with mild sedation. Reported side effects are usually mild and short-lived, such as soreness or temporary swelling. Most international patients stay in Medellín for two to five days. Which cells do you use? Passage 3 mesenchymal stem cells from umbilical cord Wharton’s jelly, donated after healthy scheduled births with maternal consent and screening. Next steps If you are asking whether you have to have hip surgery, start with a structured non-surgical programme. For selected patients who meet clear criteria and want to explore regenerative options, mesenchymal stem cell therapy may be a useful adjunct. The decision should be individualised and based on imaging, symptoms, prior treatment response and informed patient preference. References American Academy of Orthopaedic Surgeons. (2019). Management of osteoarthritis of the hip. aaos.org National Institute for Health and Care Excellence. (2014). Osteoarthritis: care and management (CG177). nice.org.uk Mardones, R., Jofré, C. M., et al. (2017). Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. Journal of Hip Preservation Surgery, 4(2), 159–163. academic.oup.com Management of hip osteoarthritis: harnessing the potential of mesenchymal stem cells — a systematic review. (2024). PubMed Central This article is for general information and does not constitute medical advice. Stem cell therapy does not guarantee results and is not a cure. Eligibility requires review of your medical history and
Alternatives to Knee Replacement Surgery: When Regenerative Medicine Makes Sense
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Knee & joints Alternatives to Knee Replacement Surgery: When Regenerative Medicine Makes Sense Evidence-based non-surgical options, where stem cell therapy fits, and when knee replacement is still the right answer. By Dr. Diana ReyesAugust 2026 In short: Most patients with knee osteoarthritis should begin with a structured non-surgical plan — exercise, weight management, physical therapy and targeted medication. Regenerative options, including mesenchymal stem cell therapy, may be reasonable for selected patients with mild-to-moderate disease who have already tried conservative care. For advanced structural damage, knee replacement remains the more predictable route to pain relief. Start with what the guidelines recommend Knee replacement is a definitive option for advanced joint disease, but most patients should pursue a stepwise approach beginning with conservative care. National guidance emphasises education, exercise, weight management and targeted medical treatments before arthroplasty is considered (NICE, 2014; ACR/Arthritis Foundation, 2020). Non-surgical essentials Education and self-management: disease education, activity modification and self-management programmes. Exercise and physical therapy: quadriceps strengthening, range-of-motion work and neuromuscular training. Weight loss: even modest reductions of 5–10% improve symptoms in patients who are overweight. Analgesics and topical agents: paracetamol and NSAIDs, oral or topical, chosen on safety profile. Bracing and orthotics: useful in unicompartmental disease or malalignment. Intra-articular injections: corticosteroids for flares; the evidence for hyaluronic acid is mixed. If these measures fail to produce acceptable symptom relief and function, referral for surgical assessment is reasonable. What regenerative medicine is, and what the evidence says Regenerative approaches aim to reduce pain and improve joint function by modulating inflammation and supporting tissue repair. The two most common options are platelet-rich plasma (PRP) and mesenchymal stem/stromal cell (MSC) treatments. Platelet-rich plasma (PRP) PRP is an autologous blood-derived injection concentrated in platelets and growth factors that can reduce inflammation, modulate pain signalling and support local tissue healing. Clinical studies in mild-to-moderate knee osteoarthritis and some tendon injuries report pain relief and functional improvement lasting months, with a favourable safety profile because it uses the patient’s own blood. PRP is relatively low-cost, minimally invasive and repeatable. It is best suited to patients with early-to-moderate degenerative changes who have already failed first-line conservative care. Mesenchymal stem cells (MSCs) MSC therapies — in our case derived from umbilical cord Wharton’s jelly — have anti-inflammatory, immunomodulatory and trophic effects that may reduce pain and support tissue repair processes. Early clinical studies and case series report improvements in pain, function and sometimes imaging biomarkers in patients with mild-to-moderate joint degeneration. MSC treatments can be combined with rehabilitation protocols. How the two differ The distinction is mechanistic rather than a ranking. Stem cell treatments deliver living cells with broader biologic activity — paracrine signalling, immune modulation and secretion of growth factors — whereas PRP delivers a concentrated but finite pool of platelets and growth factors. Head-to-head clinical evidence establishing that one is superior to the other for knee osteoarthritis is still limited, and the right choice depends on the stage of disease, the patient’s goals and clinical judgement. Any clinic presenting one as definitively better than the other is ahead of the published data. When regenerative therapy may be appropriate Regenerative options may be worth discussing if the patient: Has persistent pain and functional limitation after an adequate trial of guideline-directed conservative care, typically over several months or years. Has stage 1, 2 or 3 osteoarthritis. Wishes to delay arthroplasty because of age, occupation or preference, and understands that outcomes vary between patients. Has realistic expectations, accepts the cost, and is medically suitable — no active infection, uncontrolled systemic disease, or contraindications to the procedure. When surgery remains the correct indication Knee replacement, partial or total, is typically indicated when: Severe pain substantially limits daily activities or sleep despite optimised non-surgical care. Radiographs show advanced joint destruction with deformity, instability or bone-on-bone disease. In those situations, arthroplasty provides more predictable symptomatic and functional improvement, and we will say so. How Stem Cells Colombia approaches this Comprehensive assessment: we confirm that conservative measures have been optimised, review imaging, and evaluate whether regenerative therapy suits the patient’s disease stage and goals. Standardised protocols: defined cell processing and delivery methods under strict sterility and safety protocols, with application guided by ultrasound in the operating room. Multimodal plan: stem cell treatment is offered as part of an integrated plan including rehabilitation and pain management. Informed consent and transparency: patients receive clear counselling on expected benefits, potential risks and likely costs. You can read more about the cells we use and why, or see our knee and joint treatment in detail. Patient selection and realistic expectations Patients most likely to benefit are those with focal or mild-to-moderate cartilage loss, fewer comorbidities and realistic expectations. Some patients report meaningful pain relief and improved function lasting months to years; others have limited benefit. Results vary from person to person, and no regenerative treatment can be guaranteed to work. Frequently asked questions Do I have to have knee replacement surgery? Not necessarily, and not immediately. Guidelines recommend a structured non-surgical programme first. Surgery becomes the reasonable next step when that programme fails and imaging shows advanced structural damage. Can stem cell therapy regrow cartilage? There is no reliable evidence that stem cell therapy regenerates cartilage to a normal state. The reported effects in clinical studies are mainly on